Psoriasis and metabolic syndrome may develop interdependently due to a shared immunopathogenesis involving chronic low-level inflammation mediated by pro-inflammatory cytokines such as IFN-gamma, IL-17, IL-23, and TNF-alpha [14, 22–24]. The gene discussed is TNF; the disease is metabolic syndrome.